Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"

Mod Pathol. 2021 Nov;34(11):2089-2090. doi: 10.1038/s41379-021-00876-w. Epub 2021 Jul 27.

Authors

David Suster¹, Michael Michal², Saul Suster³

Affiliations

¹ Department of Pathology, Rutgers University Hospital, New Jersey Medical School, Newark, NJ, USA.
² Department of Pathology, Faculty of Medicine in Plzen, Charles University, Czechia, Czech Republic.
³ Department of Pathology, The Medical College of Wisconsin, Milwaukee, WI, USA. ssuster@mcw.edu.

PMID: 34316009
DOI: 10.1038/s41379-021-00876-w

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Papillary* / pathology
Humans
Mutation
Thyroid Cancer, Papillary / pathology
Thyroid Neoplasms* / pathology